FOXO TECHNOLOGIES INC. Interest Expense, Other
FOXO TECHNOLOGIES INC. (FOXO) reported Interest Expense, Other of $973.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2026-05-15
- FOXO TECHNOLOGIES INC. interest expense, other for the quarter ending 2026-03-31 was $973.00K, a 9.35% increase year-over-year.
- FOXO TECHNOLOGIES INC. interest expense, other for the quarter ending 2025-03-31 was $889.79K.
| Period end | Interest Expense, Other 3 month |
|---|---|
| 2026-03-31 | $973.00K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $889.79K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |